204 related articles for article (PubMed ID: 15668002)
1. Novel IMP-1 metallo-beta-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1.
Moloughney JG; D Thomas J; Toney JH
FEMS Microbiol Lett; 2005 Feb; 243(1):65-71. PubMed ID: 15668002
[TBL] [Abstract][Full Text] [Related]
2. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
3. IMP-51, a novel IMP-type metallo-β-lactamase with increased doripenem- and meropenem-hydrolyzing activities, in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
Tada T; Nhung PH; Miyoshi-Akiyama T; Shimada K; Phuong DM; Anh NQ; Ohmagari N; Kirikae T
Antimicrob Agents Chemother; 2015 Nov; 59(11):7090-3. PubMed ID: 26282421
[TBL] [Abstract][Full Text] [Related]
4. An in silico approach for understanding the molecular evolution of clinically important metallo-beta-lactamases.
Pal A; Tripathi A
Infect Genet Evol; 2013 Dec; 20():39-47. PubMed ID: 23954421
[TBL] [Abstract][Full Text] [Related]
5. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
6. Metallo-beta-lactamase inhibitors: promise for the future?
Toney JH; Moloughney JG
Curr Opin Investig Drugs; 2004 Aug; 5(8):823-6. PubMed ID: 15600238
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activity of ertapenem against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated in Spain.
Hernández JR; Velasco C; Romero L; Martínez-Martínez L; Pascual A
Int J Antimicrob Agents; 2006 Nov; 28(5):457-9. PubMed ID: 17008066
[TBL] [Abstract][Full Text] [Related]
8. Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
Jones RN; Sader HS; Fritsche TR
Diagn Microbiol Infect Dis; 2005 May; 52(1):71-4. PubMed ID: 15878447
[TBL] [Abstract][Full Text] [Related]
9. Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase.
Buzzoni V; Blazquez J; Ferrari S; Calò S; Venturelli A; Costi MP
Bioorg Med Chem Lett; 2004 Aug; 14(15):3979-83. PubMed ID: 15225711
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistance in bacteria: novel metalloenzyme inhibitors.
Kim SK; Sims CL; Wozniak SE; Drude SH; Whitson D; Shaw RW
Chem Biol Drug Des; 2009 Oct; 74(4):343-8. PubMed ID: 19751419
[TBL] [Abstract][Full Text] [Related]
11. Understanding the longevity of the beta-lactam antibiotics and of antibiotic/beta-lactamase inhibitor combinations.
Buynak JD
Biochem Pharmacol; 2006 Mar; 71(7):930-40. PubMed ID: 16359643
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new meropenem-EDTA double-ended Etest strip for the detection of the cfiA metallo-beta-lactamase gene in clinical isolates of Bacteroides fragilis.
Bogaerts P; Engelhardt A; Berhin C; Bylund L; Ho P; Yusof A; Glupczynski Y
Clin Microbiol Infect; 2008 Oct; 14(10):973-7. PubMed ID: 18828856
[TBL] [Abstract][Full Text] [Related]
13. Activity of meropenem as serine carbapenemases evolve in US Medical Centers: monitoring report from the MYSTIC Program (2006).
Rhomberg PR; Deshpande LM; Kirby JT; Jones RN
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):425-32. PubMed ID: 17662557
[TBL] [Abstract][Full Text] [Related]
14. Escherichia coli: development of carbapenem resistance during therapy.
Hong T; Moland ES; Abdalhamid B; Hanson ND; Wang J; Sloan C; Fabian D; Farajallah A; Levine J; Thomson KS
Clin Infect Dis; 2005 May; 40(10):e84-6. PubMed ID: 15844056
[TBL] [Abstract][Full Text] [Related]
15. Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem.
Yano H; Kuga A; Okamoto R; Kitasato H; Kobayashi T; Inoue M
Antimicrob Agents Chemother; 2001 May; 45(5):1343-8. PubMed ID: 11302793
[TBL] [Abstract][Full Text] [Related]
16. 3-mercapto-1,2,4-triazoles and N-acylated thiosemicarbazides as metallo-β-lactamase inhibitors.
Faridoon ; Hussein WM; Vella P; Islam NU; Ollis DL; Schenk G; McGeary RP
Bioorg Med Chem Lett; 2012 Jan; 22(1):380-6. PubMed ID: 22115595
[TBL] [Abstract][Full Text] [Related]
17. Metallo-β-lactamase inhibitory activity of 3-alkyloxy and 3-amino phthalic acid derivatives and their combination effect with carbapenem.
Hiraiwa Y; Morinaka A; Fukushima T; Kudo T
Bioorg Med Chem; 2013 Sep; 21(18):5841-50. PubMed ID: 23920484
[TBL] [Abstract][Full Text] [Related]
18. Contributions of IMP-10 metallo-beta-lactamase, the outer membrane barrier and the MexAB-OprM efflux system to high-level carbapenem resistance in Pseudomonas aeruginosa.
Zhao WH; Hu Z; Chen G; Ito R; Hu ZQ
Chemotherapy; 2009; 55(3):168-74. PubMed ID: 19420932
[TBL] [Abstract][Full Text] [Related]
19. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
Thomson JM; Distler AM; Bonomo RA
Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli.
Puerto AS; Fernández JG; del Castillo Jde D; Pino MJ; Angulo GP
Diagn Microbiol Infect Dis; 2006 Feb; 54(2):135-9. PubMed ID: 16406187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
